Johan Wiesel stated, 'Medimi and Medthings share the same vision of making medicine management better and safer for patients through the use of innovative solutions,' highlighting the synergy between both companies.
The acquisition will be carried out by issuing over €6 million worth of new Medimi shares to Medthings' shareholders, resulting in a joint business valued at €8.5 million.
The combined entity aims to generate synergies in revenue and cost, with Medthings projected to achieve positive operating profit by 2027, reflecting their plans for growth.
Medimi sees the integration of Medthings as crucial in supporting their goal to grow by at least 50 percent annually in the upcoming years.
Collection
[
|
...
]